Industry News - Tag: GlaxoSmithKline

You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

GSK gets a lift from Pfizer and COVID-19
Premium

1 May 2020

Worldwide sales at GlaxoSmithKline's (GSK's) Consumer Healthcare business increased by 46% at constant exchange rates in the first quarter of 2020, following consolidation of Pfizer’s Consumer Healthcare products and the COVID-19 pandemic.

Read the full story

People in brief | CHPA, HMPC, GlaxoSmithKline

20 March 2020

The US Consumer Healthcare Products Association (CHPA) has created the new position of vice president for scientific affairs and dietary supplements, Europe’s Committee for Herbal Medicinal Products (HMPC) has elected a new chair, and GlaxoSmithKline (GSK) has a new non-executive director.

Read the full story

Voltaren switches to OTC status in the US

19 February 2020

The US Food and Drug Administration (FDA) has switched GlaxoSmithKline’s (GSK’s) topical pain reliever Voltaren (diclofenac sodium topical gel 1%) from prescription-to-OTC status. GSK said the OTC version, called Voltaren Arthritis Pain, would be “available on US shelves in spring 2020”.

Read the full story